Screening and identification of a novel PGAM5-specific inhibitor for attenuating multi-organ injury

These findings establish PGAM5 as a druggable target in organ injury and identify PD as a natural compound with favorable safety and strong translational potential, providing a foundation for necroptosis-targeted therapeutic development.